# An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on Lung Cancer Patients

> **NCT07142057** · — · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Guangzhou Medical University** · enrollment: 500 (estimated)

## Conditions studied

- LUNG CANCER

## Interventions

- **BIOLOGICAL:** 23-valent pneumococcal vaccine

## Key facts

- **NCT ID:** NCT07142057
- **Lead sponsor:** The First Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-09-01
- **Final completion:** 2030-09-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07142057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07142057, "An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on Lung Cancer Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07142057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*